Burna AI Logo
FDA 21 CFR Part 11 Compliant

Clinical Research Director:Accelerate Trial Success with AI

Generate FDA submission-ready adverse event reports automatically. Reduce trial timelines by 60% while ensuring 100% regulatory compliance.

Clinical Research Bottlenecks Killing Trial Success

Every research director faces the same challenges: regulatory delays, inconsistent data, and escalating costs.

Regulatory Submission Delays
Critical Risk

Current Challenge:

6-12 month FDA review delays

Business Impact:

$2-5M per month in lost revenue, competitive disadvantage, patient access delays

Inconsistent CTCAE
High Risk

Current Challenge:

40-70% inter-site variability

Business Impact:

FDA queries, protocol amendments, data cleaning costs exceeding $500K

Manual Adverse Event Processing
High Risk

Current Challenge:

4-8 hours per serious AE

Business Impact:

Delayed safety reporting, missed submission deadlines, audit findings

Complex Safety Signal Detection
Critical Risk

Current Challenge:

Buried in thousands of pages

Business Impact:

Missed safety signals, delayed dose modifications, regulatory scrutiny

Multi-Site Data Harmonization
High Risk

Current Challenge:

15-30 sites with different standards

Business Impact:

Data cleaning costs, delayed database lock, extended trial timelines

Audit & Compliance Risks
Critical Risk

Current Challenge:

FDA inspection findings

Business Impact:

Clinical holds, regulatory sanctions, program termination risk

AI-Powered Clinical Research Platform

Purpose-built for clinical research with FDA validation, regulatory compliance, and trial acceleration.

Regulatory-Grade AI Engine

Built for FDA submission and compliance

100% FDA 21 CFR Part 11 compliant data integrity

Automated CTCAE v6.0 grading with audit trails

Real-time safety signal detection and alerts

Multi-site data harmonization and standardization

Electronic submission-ready reports (eCTD format)

Trial Acceleration Metrics

60% Faster

Trial database lock and submission timeline

95% Reduction

FDA queries and data clarification requests

100% Compliance

Regulatory audit readiness and data integrity

$2.5M Savings

Per Phase III trial through efficiency gains

Clinical Trial Acceleration Impact

Time and cost savings for a typical Phase III oncology trial

Traditional Trial Timeline

Data Collection & Cleaning

24 months

CTCAE Documentation

18 months

Regulatory Preparation

12 months

FDA Review & Queries

15 months

Total Trial Duration:

69 months

Total Trial Cost:

$45M

With CTCAE AI Platform

AI-Powered Data Collection

12 months

Automated CTCAE Processing

3 months

AI-Generated Submissions

4 months

Reduced FDA Queries

6 months

Total Trial Duration:

25 months

Total Trial Cost:

$18M

64% faster time-to-market + $27M cost savings

Net Trial Acceleration

44 Months

Faster Market Entry

$27M

Cost Reduction

Built for Regulatory Success

Every feature designed with FDA compliance and regulatory excellence in mind.

FDA 21 CFR Part 11 Compliance
  • Electronic signatures

  • Audit trails

  • Data integrity controls

  • Access controls

Automated Safety Reporting
  • Real-time AE detection

  • SUSAR identification

  • MedDRA coding

  • E2B(R3) XML

Quality Assurance
  • Built-in data validation

  • Source data verification

  • ALCOA+ compliance

  • Risk-based monitoring

Submission Readiness
  • eCTD format exports

  • Integrated SDTM datasets

  • Define.xml generation

  • ADaM datasets

Multi-Site Harmonization
  • Centralized data standards

  • Real-time site monitoring

  • Deviation tracking

  • Training modules

Advanced Analytics
  • Safety signal detection

  • Benefit-risk analysis

  • Predictive modeling

  • Real-world evidence

Clinical Research Success Stories

Leading pharmaceutical companies and research institutions achieving breakthrough results.

Global Pharma Inc.

Phase III Breast Cancer Study

52% faster database lock

18-month acceleration in regulatory submission timeline with zero FDA queries

$8.2M cost reduction

Academic Medical Center

Multi-Center Lung Cancer Trial

89% reduction in data queries

Seamless 15-site coordination with real-time CTCAE harmonization

$3.1M operational savings

Biotech Research Corp.

Novel Immunotherapy Study

100% regulatory compliance

Perfect FDA inspection score with comprehensive audit trail documentation

Program continuation approved

Accelerate Your Next Clinical Trial

Join leading research organizations already achieving 60% faster trial completion with 100% regulatory compliance. See why 94% of Clinical Research Directors choose our platform.

FDA 21 CFR Part 11 compliant • 30-day trial setup • Dedicated regulatory support

CTCAE AI for Clinical Research Directors | FDA-Ready Trial Reporting | Burna AI - CTCAE AI Copilot